Correlation Between OncoVista Innovative and Avax Techs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OncoVista Innovative and Avax Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoVista Innovative and Avax Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoVista Innovative Therapies and Avax Techs, you can compare the effects of market volatilities on OncoVista Innovative and Avax Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoVista Innovative with a short position of Avax Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoVista Innovative and Avax Techs.

Diversification Opportunities for OncoVista Innovative and Avax Techs

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between OncoVista and Avax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding OncoVista Innovative Therapies and Avax Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avax Techs and OncoVista Innovative is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoVista Innovative Therapies are associated (or correlated) with Avax Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avax Techs has no effect on the direction of OncoVista Innovative i.e., OncoVista Innovative and Avax Techs go up and down completely randomly.

Pair Corralation between OncoVista Innovative and Avax Techs

Given the investment horizon of 90 days OncoVista Innovative Therapies is expected to generate 1.87 times more return on investment than Avax Techs. However, OncoVista Innovative is 1.87 times more volatile than Avax Techs. It trades about 0.05 of its potential returns per unit of risk. Avax Techs is currently generating about -0.04 per unit of risk. If you would invest  0.01  in OncoVista Innovative Therapies on November 2, 2024 and sell it today you would earn a total of  0.01  from holding OncoVista Innovative Therapies or generate 100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

OncoVista Innovative Therapies  vs.  Avax Techs

 Performance 
       Timeline  
OncoVista Innovative 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OncoVista Innovative Therapies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent forward indicators, OncoVista Innovative unveiled solid returns over the last few months and may actually be approaching a breakup point.
Avax Techs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avax Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Avax Techs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

OncoVista Innovative and Avax Techs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OncoVista Innovative and Avax Techs

The main advantage of trading using opposite OncoVista Innovative and Avax Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoVista Innovative position performs unexpectedly, Avax Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avax Techs will offset losses from the drop in Avax Techs' long position.
The idea behind OncoVista Innovative Therapies and Avax Techs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
CEOs Directory
Screen CEOs from public companies around the world